171 related articles for article (PubMed ID: 102281)
1. [Electrophysiological effects of chloroacetyl ajmaline in Wolff-Parkinson-White syndrome].
Touboul P; Gressard A; Atallah G; Chatelain MT; Delahaye JP
Arch Mal Coeur Vaiss; 1978 Jul; 71(7):808-15. PubMed ID: 102281
[TBL] [Abstract][Full Text] [Related]
2. [Action of chloro-acetyl-ajmaline on the electrical properties of the human heart].
Touboul P; Jandot V; Thizy JF; Chatelain MT; Delahaye JP
Arch Mal Coeur Vaiss; 1977 Sep; 70(9):973-80. PubMed ID: 415694
[TBL] [Abstract][Full Text] [Related]
3. Effect of atropine and isoproterenol on tachycardia induction in asymptomatic patients with Wolff-Parkinson-White electrocardiographic pattern.
Kim YH; Leitch JW; Klein GJ; Yee R; Leather RA
Can J Cardiol; 1992 Sep; 8(7):716-20. PubMed ID: 1422992
[TBL] [Abstract][Full Text] [Related]
4. [An electrophysiologic and electropharmacological study of functional properties of the bundle of Kent in Wolff-Parkinson-White syndrome].
Costantini M; Chimienti M; Zardini M; Klersy C; Guasti L; Salerno JA
Cardiologia; 1989 Apr; 34(4):365-74. PubMed ID: 2758442
[TBL] [Abstract][Full Text] [Related]
5. [Action of ajmaline on the accessory excitation conduction in WPW-syndrome].
Seipel L; Breithardt G; Wiebringhaus E; Loogen F
Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():337-9. PubMed ID: 611976
[No Abstract] [Full Text] [Related]
6. [The clinical significance of the ajmaline test in the noninvasive diagnosis of the Wolff-Parkinson-White syndrome].
Neuzner J; Pitschner HF; Jakob H; Schlepper M
Dtsch Med Wochenschr; 1994 Jul; 119(28-29):985-9. PubMed ID: 8039452
[TBL] [Abstract][Full Text] [Related]
7. [Electrophysiological effects of ajmaline on the human conduction system (author's transl)].
Alboni P; Malacarne E; Pedroni P
G Ital Cardiol; 1978; 8(7):752-63. PubMed ID: 680433
[TBL] [Abstract][Full Text] [Related]
8. [Electrophysiologic effects of amiodarone in Wolf-Parkinson-White syndrome].
Touboul P; Porte J; Huerta F; Delahaye JP
Arch Mal Coeur Vaiss; 1976 Aug; 69(8):855-63. PubMed ID: 823923
[TBL] [Abstract][Full Text] [Related]
9. [Wolff-Parkinson-White syndrome after 50 yars of age. Clinical and electrophysiological data].
Lévy S; Borde C; Dupon J; Bémurat M; Gérard R; Bricaud H
Arch Mal Coeur Vaiss; 1980 Jul; 73(7):817-23. PubMed ID: 6773494
[TBL] [Abstract][Full Text] [Related]
10. [Preexcitation syndrome and ajmaline].
Sepúlveda G; Rosselot E; Kandora H; Soto O; Mordoch I; Ahumada J
Rev Esp Cardiol; 1976; 29(6):489-97. PubMed ID: 796910
[No Abstract] [Full Text] [Related]
11. [Value of transesophageal auricular stimulation for evaluating the accessory pathway and effect of treatment in Wolf-Parkinson-White syndrome].
Kieny JR; Kraenner C; Facello A; Roul G; Mossard JM; Bareiss P; Sacrez A
Arch Mal Coeur Vaiss; 1989 Sep; 82(9):1585-93. PubMed ID: 2510679
[TBL] [Abstract][Full Text] [Related]
12. [Oral propranolol in Wolff-Parkinson-White syndrome. Electrophysiological data].
Dolla E; Levy S; Cointe R; Moyal C; Bru P; Rossi P; Gérard R
Arch Mal Coeur Vaiss; 1991 Jul; 84(7):917-21. PubMed ID: 1929709
[TBL] [Abstract][Full Text] [Related]
13. [Sotalol in the Wolff-Parkinson-White syndrome: an electrophysiological and clinical study].
Inama G; Furlanello F; Vergara G; Guarnerio M; Braito G; Nassivera E
G Ital Cardiol; 1992 Jun; 22(6):701-13. PubMed ID: 1426808
[TBL] [Abstract][Full Text] [Related]
14. Value of the ajmaline-procainamide test to predict the effect of long-term oral amiodarone on the anterograde effective refractory period of the accessory pathway in the Wolff-Parkinson-White syndrome.
Brugada P; Dassen WR; Braat S; Gorgels AP; Wellens HJ
Am J Cardiol; 1983 Jul; 52(1):70-2. PubMed ID: 6858931
[TBL] [Abstract][Full Text] [Related]
15. [Intravenous flecainide in Wolff-Parkinson-White syndrome: a test for evaluation of the refractory period of the anomalous pathway. Comparison with ajmaline].
Klersy C; Marangoni E; Salerno JA; Guasti L; Chimienti M; Morellini MC; li Bergolis M; Moizi M; Tronconi L; Bobba P
Cardiologia; 1988 May; 33(5):531-5. PubMed ID: 3139291
[No Abstract] [Full Text] [Related]
16. Electrophysiological studies in patients with the Wolf-Parkinson-White syndrome.
Farré J; Ross DL; Wiener I; Bär FW; Vanagt E; Wellens HJ
Herz; 1979 Feb; 4(1):38-46. PubMed ID: 437670
[TBL] [Abstract][Full Text] [Related]
17. [Electrophysiological action of disopyramide].
Grosu AA; Malakhov VI; Smetnev AS
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1982; 5(2):51-5. PubMed ID: 7138657
[TBL] [Abstract][Full Text] [Related]
18. [Effects of oral sotalol on the conduction of accessory atrioventricular pathways].
Blanc JJ; Boschat J; Ollivier JP; Penther P
Arch Mal Coeur Vaiss; 1985 Jul; 78(7):1097-102. PubMed ID: 3929739
[TBL] [Abstract][Full Text] [Related]
19. Effect of procaine amide, quinidine, and ajmaline in the Wolff-Parkinson-White syndrome.
Wellens HJ; Durrer D
Circulation; 1974 Jul; 50(1):114-20. PubMed ID: 4835257
[No Abstract] [Full Text] [Related]
20. [Sotalol in supraventricular tachycardia. Electrophysiologic measurements in Wolff-Parkinson-White syndrome and AV node re-entry tachycardia].
Manz M; Kuhl AJ; Lüderitz B
Z Kardiol; 1985 Sep; 74(9):500-5. PubMed ID: 4060827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
